title: Australia reschedules naloxone for opioid overdose.
authors.affiliation: National Drug Research Institute, Curtin University, Perth, WA s.lenton@curtin.edu.au.
authors.forename: Simon R
authors.initials: SR
authors.lastname: Lenton
authors.affiliation: Burnet Institute, Melbourne, VIC.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Dietze
authors.affiliation: Sydney Medically Supervised Injecting Centre, Sydney, NSW.
authors.forename: Marianne
authors.initials: M
authors.lastname: Jauncey
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects; D001315:Australia; D062787:Drug Overdose / Q000188:drug therapy* / Q000209:etiology; D004335:Drug and Narcotic Control; D006699:Home Care Services; D006801:Humans; D009270:Naloxone / Q000145:classification* / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000145:classification* / Q000627:therapeutic use; D004366:Nonprescription Drugs / Q000145:classification* / Q000627:therapeutic use
chemical_list: D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D004366:Nonprescription Drugs; D009270:Naloxone